Ampersand Capital Partners

Ampersand Capital Partners is a middle market private equity firm based in Massachusetts, established in 1988. The firm focuses on making investments primarily in two sectors: healthcare and industrial. With a commitment to identifying and supporting growth opportunities, Ampersand seeks to partner with companies that have the potential for significant development within these industries. Through its strategic investments, the firm aims to enhance the operational capabilities and market positions of its portfolio companies.

Scott Anderson

Associate

David Q. Anderson

General Partner

Stuart A. Auerbach

Advisory Partner

Jared J. Bartok

Advisory Partner

Richard A. Charpie

Founder

Melanie Fan

Principal

Herbert Hooper

Managing Partner

Thomas de Jager

Vice President, Business Development

Max R. Keeley

Associate

Eric B. Lev

General Partner

Greg W. Magoon

Vice President

Jenna N. Mark

Associate

Alex Marotto

Senior Associate

Caroline L. Marple

Director of Marketing

Arya Mehrabanzad

Vice President

Dana L. Niles

Partner and COO

David J. Parker

General Partner

David B. Patteson

Partner

Marina Pellón-Consunji

Partner

Mario J. Reto

Senior Associate

Geoffrey P. Teillon

Partner

Trevor Wahlbrink

Partner

Patrick D. Walsh

Operating Partner

Past deals in Vermont

Vernal Biosciences

Venture Round in 2022
Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.